Washington D.C. Medical Marijuana Patient Count Rises to 99,710, Up Over 5,000 Since December
- Washington, D.C.’s medical marijuana market generated $8.74 million in sales in January 2026, with dispensaries, cultivation centers, and manufacturers contributing $5.7 million, $784,688, and $2.24 million respectively.
- Patient enrollment reached 99,710 unique patients in January, increasing from previous months, with 668 healthcare providers and 31 registered caregivers participating in the program.
- D.C. residents accounted for $3.58 million in sales, primarily through in-store purchases ($3.32 million), while reciprocity patients contributed $451,456 in sales with 2,101 unique visitors.
- Self-certified temporary patients generated $1.68 million in sales, with Virginia and Maryland being the top states for non-D.C. patient participation, highlighting continued program growth and nearly doubling sales compared to January 2025.
Washington, D.C.’s medical marijuana market generated $8,741,275 in total sales in January, according to the Alcoholic Beverage and Cannabis Administration’s January 2026 Medical Cannabis Program Report. Of that total, dispensaries accounted for $5,715,068 in sales, cultivation centers reported $784,688, and manufacturers recorded $2,241,519. While January’s combined total was slightly lower than December’s $9,087,476, it marked a significant increase compared to January 2025, when total sales were $4,597,995.
Patient enrollment also continued its upward trajectory. The District reported 99,710 total unique patients in January, up from 94,067 in December and 90,811 in November. The number of healthcare providers participating in the program rose to 668, while registered caregivers held steady at 31.
Among D.C. residents, 20,800 unique patients were registered in January, with total sales reaching $3,584,908. In-store purchases accounted for $3,317,733 of that figure, while delivery sales totaled $267,176. The average sale for D.C. residents was $64.
Reciprocity patients—those visiting from other states—generated $451,456 in sales during January, down from $472,175 in December. There were 2,101 unique reciprocity patients recorded for the month.
The report also shows continued participation from self-certified temporary patients, who generated $1,678,703 in total sales in January. Virginia and Maryland remained the top states for non-D.C. patient participation.
With enrollment nearing 100,000 patients and year-over-year sales nearly doubling compared to January 2025, the District’s medical marijuana program continues to expand, even as monthly sales fluctuate.